ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
126.77 -0.11  -0.09% NASDAQ Nov 28, 2:00PM BATS Real time Currency in USD
View Full Chart
BIB Price Chart

BIB Description

ProShares Ultra Nasdaq Biotechnology is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 449.68M USD assets under management. It has a Forecasted PE Ratio of 29.59 and a Forecasted Price to Book Value of 6.685. The fund has a net expense ratio of 0.95%, turns over its positions 26.00% per year, and is traded on the NASDAQ.

BIB Key Info

Expense Ratio (10-1-14) 0.95%
Assets Under Management (11-26-14) 449.68M
30-Day Average Volume (11-26-14) 256942.1
Net Asset Value (11-26-14) 126.67
Discount or Premium to NAV (11-26-14) 0.17%
Turnover Ratio (5-31-14) 26.00%
View All BIB News
Edit Sources

BIB News

BIB Asset Allocation

Type % Net % Long % Short
Cash -99.42% 29.97% 129.4%
Stock 163.8% 164.6% 0.77%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 35.62% 35.62% 0.00%
As of Sept. 30, 2014

BIB Region Exposure

Americas 95.77%
North America 95.77%
Latin America 0.00%
Greater Europe 4.17%
United Kingdom 1.88%
Europe Developed 2.29%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.06%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.06%
Market Classification
% Developed Markets 99.94%
% Emerging Markets 0.06%
As of Sept. 30, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Sept. 30, 2014

BIB Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Sept. 30, 2014
View More Holdings

BIB Top 10 Holdings

Name % Weight Price Chg %
Nasdaq Biotechnology Index Swap Ubs Ag 55.15% -- --
Ishares Biotech (Ibb) Swap Deutsche Bank Ag 25.99% -- --
Nasdaq Biotechnology Index Swap Credit Suisse International 19.16% -- --
Nasdaq Biotechnology Index Swap Bank Of America, Na 10.33% -- --
Amgen Inc 5.80% 165.31 +0.36%
Celgene Corp 5.74% 113.69 +0.96%
Gilead Sciences Inc 5.70% 100.20 -0.10%
Biogen Idec Inc 5.55% 307.62 +0.89%
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 5.48% -- --
Nasdaq Biotechnology Index Swap Deutsche Bank Ag 5.20% -- --
As of Sept. 30, 2014
Get Quote for
Advertisement

BIB Basic Info

Style
Asset Class Alternative
Prospectus Objective Specialty - Health
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD 200.0%
Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2014
Last Prospectus Date 10/1/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

BIB Manager Info

Name Tenure
Charles Lowery 1.08 yrs
Michael Neches 1.08 yrs

BIB Risk Info

Beta 1.947
30 Day Average Volatility 42.28%

BIB Fundamentals

Dividend Yield TTM (11-28-14) 0%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield 0.22%
Forecasted PE Ratio 29.59
Forecasted Price to Sales Ratio 7.222
Forecasted Price to Book Ratio 6.685
Number of Holdings 126.00
As of Sept. 30, 2014

BIB Growth Estimates

Forecasted 5 Yr Earnings Growth 15.37%
Forecasted Book Value Growth 10.37%
Forecasted Cash Flow Growth 10.96%
Forecasted Earnings Growth 30.65%
Forecasted Revenue Growth 11.95%
As of Sept. 30, 2014

BIB Performance

  Returns Total Returns
1M 10.17% 10.17%
3M 19.48% 19.48%
6M 63.62% 63.62%
1Y 74.17% 74.17%
3Y 762.1% 762.1%
5Y -- --
As of Nov. 26, 2014

BIB Flows

1M 40.06M
3M -28.93M
6M -85.24M
YTD 60.78M
1Y 68.92M
3Y 167.43M
5Y --
As of Oct. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.